U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 5,400 records

Showing results for "opioid".
Users also searched for: opioid

  1. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49606/psn-pdf
    August 01, 2010 - nausea and vomiting.(4) An epidural can provide excellent postoperative pain control, thereby lowering opioid

  2. Comparison Tables for Making Healthcare Safer Reports | Agency for Healthcare Research and Quality

    www.ahrq.gov/research/findings/making-healthcare-safer/comparison.html
    June 01, 2025 - Due to Opioids Patient Safety Practices  MHS I (2001) MHS II (2013) MHS III (2020) MHS IV (2023-24) Opioid

  3. White Paper: Standardized Library of Lumbar Spondylolisthesis Outcome Measures (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-lumbar-spondylolisthesis.pdf
    March 01, 2021 - adverse reaction being similar to the stated reason for the intervention (e.g., adverse reaction to opioid

  4. Endotracheal Tube Fallout in a Patient with Severe Obesity During Eye Surgery. | PSNet

    psnet.ahrq.gov/web-mm/endotracheal-tube-fallout-patient-severe-obesity-during-eye-surgery
    January 29, 2021 - obstruction. 16 Respiratory depressant medications such as opioids should be administered sparingly, and non-opioid … The benefits of opioid free anesthesia and the precautions necessary when employing it.

  5. Bandemia as a Harbinger of Stercoral Colitis and Impending Perforation | PSNet

    psnet.ahrq.gov/web-mm/bandemia-harbinger-stercoral-colitis-and-impending-perforation
    November 25, 2020 - shaking” at home and being weak “like a ragdoll,” which he attributed to her long history of high dose opioid … review found that 70% of patients will have a history of constipation. 4 Constipation is due to chronic opioid

  6. Making Healthcare Safer III Report | PSNet

    psnet.ahrq.gov/perspective/making-healthcare-safer-iii-report
    March 30, 2020 - the strategic goals from the Department of Health and Human Services (HHS), including addressing the opioid … Testing for CDI, CDI surveillance, antimicrobial stewardship, opioid stewardship, all those areas were … I also appreciated the work we did around opioid-related harms. … Safety May 28, 2020 Perspective Antibiotic and Opioid

  7. NIAC & Project Team Bios | The Academy

    integrationacademy.ahrq.gov/about/academy-team/niac-bios
    June 01, 2022 - Home Products Playbooks Medications for Opioid … AHRQ Initiatives EvidenceNOW: Managing Unhealthy Alcohol Use Opioid … Initiative Older Adult Opioid Initiative Other HHS Initiatives … He is also a member of Maine’s Opioid Clinical Advisory Group and Maine’s Governor has appointed him

  8. Cannabis-2022-Update-Surv-Rep-1-App-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
    January 01, 2022 - Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38 Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172) Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13 Opioid: 2 vs. 3 Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use

  9. Cer-250-Cannabis-Tables-E1-E4-2022-Update 0 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
    January 01, 2022 - Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38 Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172) Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13 Opioid: 2 vs. 3 Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use

  10. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 0 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
    May 29, 2025 - Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38 Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172) Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13 Opioid: 2 vs. 3 Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use

  11. STATISTICAL BRIEF #530: Total Expenses, Total Utilization, and Sources of Payment for Outpatient Prescription Opioids in the U.S. Adult Civilian Noninstitutionalized Population, 2017

    meps.ahrq.gov/data_files/publications/st530/stat530.shtml
    July 01, 2020 - STATISTICAL BRIEF #530: Total Expenses, Total Utilization, and Sources of Payment for Outpatient Prescription Opioids in the U.S. Adult Civilian Noninstitutionalized Population, 2017   Skip to main content An offic…

  12. Disposition of Comments Report for Nitrous Oxide for the Management of Labor Pain (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_disposition-comments.pdf
    August 23, 2012 - Or “Nitrous oxide induces release of endogenous opioid peptides in the midbrain, stimulating descending … The data for efficacy of intravenous opioid labor analgesia would suggest this description for “opioids … IV remifentanil is the most popular opioid being used for that purpose currently, but it can cause … p. 47, I think it would be helpful to note that pethidine is known as Demerol in the US and is an opioid

  13. Evaluation of the Agency for Healthcare Research and Quality Patient-Centered Outcomes Research Clinical Decision Support Initiative: Findings and Recommendations for Future Initiatives (pdf file)

    digital.ahrq.gov/sites/default/files/docs/citation/cds-evaluation-summary-report-p233201500023I.pdf
    March 23, 2022 - Clinical informatics efforts to combat the opioid crisis—Experiences from the frontline. … New strategies for using patient-centered technology to improve pain management and opioid treatment … Opioid Action Plan Psychiatry and Behavioral Health Learning Network; 2019. … New strategies for using patient-centered technology to improve pain management and opioid treatment … Improving the management of chronic pain, opioid use, and opioid use disorder in older adults: study

  14. At the American Society of Health Economists Conference, AHRQ to Highlight Its Deep Dive into COVID-19 | Agency for Healthcare Research and Quality

    www.ahrq.gov/news/blog/ahrqviews/deep-dive-into-covid19.html
    June 01, 2023 - Didem Bernard, Ph.D., will present a poster examining the effects of smoking on opioid use among adults

  15. A piece of my mind. Despite my best intentions. | PSNet

    psnet.ahrq.gov/issue/piece-my-mind-despite-my-best-intentions
    September 13, 2016 - Commentary A piece of my mind. Despite my best intentions. Citation Text: Kahn JS. Despite My Best Intentions. JAMA. 2017;318(17). doi:10.1001/jama.2017.6123. Copy Citation Format: DOI Google Scholar BibTeX EndNote X3 XML EndNote 7 XML Endnote tagged PubMedId RIS …

  16. Artificial Intelligence in Health Care: Benefits and Challenges of Machine Learning Technologies for Medical Diagnostics. | PSNet

    psnet.ahrq.gov/issue/artificial-intelligence-health-care-benefits-and-challenges-machine-learning-technologies
    October 12, 2022 - Book/Report Artificial Intelligence in Health Care: Benefits and Challenges of Machine Learning Technologies for Medical Diagnostics. Citation Text: Artificial Intelligence in Health Care: Benefits and Challenges of Machine Learning Technologies for Medical Diagnostics. Washington DC: Un…

  17. AHRQ Announces Interest in Research About the Epidemiology of Patient Safety Risks and Harms in Ambulatory Health Care Settings. | PSNet

    psnet.ahrq.gov/issue/ahrq-announces-interest-research-about-epidemiology-patient-safety-risks-and-harms-ambulatory
    August 15, 2018 - Government Resource AHRQ Announces Interest in Research About the Epidemiology of Patient Safety Risks and Harms in Ambulatory Health Care Settings. Citation Text: AHRQ Announces Interest in Research About the Epidemiology of Patient Safety Risks and Harms in Ambulatory Health Care Setti…

  18. Improving Quality of Care and Patient Outcomes During Care Transitions (R01). | PSNet

    psnet.ahrq.gov/issue/improving-quality-care-and-patient-outcomes-during-care-transitions-r01
    October 09, 2022 - Grant Announcement Improving Quality of Care and Patient Outcomes During Care Transitions (R01). Citation Text: Improving Quality of Care and Patient Outcomes During Care Transitions (R01). Rockville, MD: Agency for Healthcare Research and Quality; December 6, 2019. PA-20-068. Copy…

  19. Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional). | PSNet

    psnet.ahrq.gov/issue/using-innovative-digital-healthcare-solutions-improve-quality-point-care-r21r33-clinical
    July 22, 2024 - Grant Announcement Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional). Citation Text: Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional). Rockvill…

  20. Chemotherapy drug shortages in pediatric oncology: a consensus statement. | PSNet

    psnet.ahrq.gov/issue/chemotherapy-drug-shortages-pediatric-oncology-consensus-statement
    March 15, 2017 - Organizational Policy/Guidelines Chemotherapy drug shortages in pediatric oncology: a consensus statement. Citation Text: Decamp M, Joffe S, Fernandez C, et al. Chemotherapy drug shortages in pediatric oncology: a consensus statement. Pediatrics. 2014;133(3):e716-24. doi:10.1542/peds.201…
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

psnet.ahrq.gov (3919)

www.ahrq.gov (469)

integrationacademy.ahrq.gov (296)

effectivehealthcare.ahrq.gov (291)

hcup-us.ahrq.gov (167)

digital.ahrq.gov (155)

www.uspreventiveservicestaskforce.org (31)

meps.ahrq.gov (29)

cds.ahrq.gov (23)

cdsic.ahrq.gov (9)

datatools.ahrq.gov (8)

pso.ahrq.gov (3)